m6A-centered Drug Response Information
General Information of the Drug (ID: M6ADRUG0136)
| Name |
Liproxstatin-1
|
||||
|---|---|---|---|---|---|
| Synonyms |
Liproxstatin-1, 950455-15-9, Liproxstatin 1, Lip-1, liproxstatin1, N-(3-Chlorobenzyl)-1'H-spiro[piperidine-4,2'-quinoxalin]-3'-amine, CHEBI:173097, N-[(3-CHLOROPHENYL)METHYL]-1'H-SPIRO[PIPERIDINE-4,2'-QUINOXALIN]-3'-AMINE, N-(3-chlorobenzyl)-1'H-spiro(piperidine-4,2'-quinoxalin)-3'-amine, N-((3-chlorophenyl)methyl)-1'H-spiro(piperidine-4,2'-quinoxalin)-3'-amine, N-[(3-chlorophenyl)methyl]spiro[1,4-dihydroquinoxaline-3,4'-piperidine]-2-imine, 1-(3-chlorophenyl)-N-{1',4'-dihydrospiro[piperidine-4,2'-quinoxalin]-3'-ylidene}methanamine, MFCD14948691, C19H21ClN4, CHEMBL2094750, SCHEMBL17757281, EX-A558, Liproxstatin-1, >98% (HPLC), BCP15985, DNDI1417503, s7699, AKOS001973583, N-[(3-chlorophenyl)methyl]spiro[4H-quinoxaline-3,4'-piperidine]-2-amine, CCG-175950, CS-3994, AC-33023, BS-18273, DA-65002, HY-12726, EN300-202271, F17363, N-[(3-chlorophenyl)methyl]-1'H-spiro[piperidine-4,2'-quinoxaline]-3'-amine
Click to Show/Hide
|
||||
| Structure |
 |
||||
|
3D MOL
|
|||||
| Formula |
C19H21ClN4
|
||||
| InChI |
InChI=1S/C19H21ClN4/c20-15-5-3-4-14(12-15)13-22-18-19(8-10-21-11-9-19)24-17-7-2-1-6-16(17)23-18/h1-7,12,21,24H,8-11,13H2,(H,22,23)
|
||||
| InChIKey |
YAFQFNOUYXZVPZ-UHFFFAOYSA-N
|
||||
| PubChem CID | |||||